NRAS, FLT3 and TP53 mutations in patients with myelodysplastic syndrome and a del(5q).

NRAS, FLT3 and TP53 mutations in patients with myelodysplastic syndrome and a del(5q).

Mutations of the NRAS and TP53 genes and internal tandem duplication (ITD) of the FLT3 gene are among the most frequently observed molecular abnormalities in the myelodysplastic syndromes (MDS) and acute myeloid leukemia (AML). We sought to determine the incidence of these abnormalities in patients...

書誌詳細
主要な著者:	Fidler, C, Watkins, F, Bowen, D, Littlewood, T, Wainscoat, J, Boultwood, J
フォーマット:	Journal article
言語:	English
出版事項:	2004

類似資料

The role and impact of Del(5q) and TP53 mutations on haematopoietic stem and progenitor cells during the progression of Myelodysplastic Syndrome to Acute Myeloid Leukaemia
著者:: Doolittle, H
出版事項: (2017)

Mutations in PTPN11 are rare in adult myelodysplastic syndromes and acute myeloid leukemia.
著者:: Watkins, F, 等
出版事項: (2004)

TP53 mutation status divides myelodysplastic syndromes with complex karyotypes into distinct prognostic subgroups
著者:: Haase, D, 等
出版事項: (2019)

Telomere length in myelodysplastic syndromes.
著者:: Boultwood, J, 等
出版事項: (1995)

Gene expression profiling in patients with myelodysplastic syndromes, including patients with the del(5q)
著者:: Boultwood, J
出版事項: (2009)

Expression profiling of CD34+cells in patients with myelodysplastic syndromes with and without a del(5q).
著者:: Pellagatti, A, 等
出版事項: (2004)

Implications of TP53 allelic state for genome stability, clinical presentation and outcomes in myelodysplastic syndromes
著者:: Bernard, E, 等
出版事項: (2020)

8 Gene expression profiling in patients with myelodysplastic syndromes, including patients with the del(5q)
著者:: Boultwood, J
出版事項: (2009)

Targeted re-sequencing analysis of 25 genes commonly mutated in myeloid disorders in del(5q) myelodysplastic syndromes.
著者:: Fernandez-Mercado, M, 等
出版事項: (2013)

Gene expression profiling in 5q-syndrome and myelodysplastic syndromes.
著者:: Pellagatti, A, 等
出版事項: (2003)

TP53-mutated myelodysplastic syndrome and acute myeloid leukemia: biology, current therapy, and future directions
著者:: Daver, NG, 等
出版事項: (2022)

Gene expression profiling in the myelodysplastic syndromes.
著者:: Pellagatti, A, 等
出版事項: (2005)

Marked down-regulation of nucleophosmin-1 is associated with advanced del(5q) myelodysplastic syndrome.
著者:: Pellagatti, A, 等
出版事項: (2011)

Marked down-regulation of nucleophosmin-1 is associated with advanced del(5q) myelodysplastic syndrome
著者:: Pellagatti, A, 等
出版事項: (2011)

Clonality in the myelodysplastic syndromes.
著者:: Boultwood, J, 等
出版事項: (2001)

Expression profiling of CD34+cells in patients with myelodysplastic syndromes with and without a del(5q)
著者:: Pellagatti, A, 等
出版事項: (2005)

Genome-wide analysis of copy number change and loss of heterozygosity in myelodysplastic syndrome with del(5q) using high-density SNP arrays
著者:: Wang, L, 等
出版事項: (2007)

Molecular pathogenesis of the myelodysplastic syndromes
著者:: Boultwood, J, 等
出版事項: (1999)

Whole-exome sequencing in del(5q) myelodysplastic syndromes in transformation to acute myeloid leukemia
著者:: Pellagatti, A, 等
出版事項: (2014)

Whole-exome sequencing in del(5q) myelodysplastic syndromes in transformation to acute myeloid leukemia.
著者:: Pellagatti, A, 等
出版事項: (2014)

Progression in patients with low- and intermediate1-risk del(5q) myelodysplastic syndromes is predicted by a limited subset of mutations.
著者:: Scharenberg, C, 等
出版事項: (2016)

Telomere length in myelodysplastic syndromes.
著者:: Boultwood, J, 等
出版事項: (1997)

Genome-wide analysis of copy number changes and loss of heterozygosity in myelodysplastic syndrome with del(5q) using high-density single nucleotide polymorphism arrays.
著者:: Wang, L, 等
出版事項: (2008)

Unravelling haematopoietic stem cell dysfunction in isolated Del(5q) myelodysplastic syndromes
著者:: Stenson, L
出版事項: (2015)

FLT3, NPM1, DNMT3a and NRAS genes mutation in acute myeloid leukaemia in HUSM
著者:: Mat Yunus, Noraini
出版事項: (2015)

L-leucine increases translation of RPS14 and LARP1 in erythroblasts from del(5q) myelodysplastic syndrome patients
著者:: Bello, E, 等
出版事項: (2018)

TP53 suppression promotes erythropoiesis in del(5q) MDS, suggesting a targeted therapeutic strategy in lenalidomide-resistant patients.
著者:: Caceres, G, 等
出版事項: (2013)

The role of splicing factor mutations in the pathogenesis of the myelodysplastic syndromes.
著者:: Boultwood, J, 等
出版事項: (2014)

Mutation analysis of the SPARC gene in the 5q-syndrome.
著者:: Fidler, C, 等
出版事項: (2000)

GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR GENE IN MYELODYSPLASTIC SYNDROMES - REPLY
著者:: Boultwood, J, 等
出版事項: (1991)

MOLECULAR DELINEATION OF THE CRITICAL REGION OF THE 5Q-CHROMOSOME IN THE 5Q-SYNDROME
著者:: Boultwood, J, 等
出版事項: (1993)

Low expression of the putative tumour suppressor gene gravin in chronic myeloid leukaemia, myelodysplastic syndromes and acute myeloid leukaemia.
著者:: Boultwood, J, 等
出版事項: (2004)

Clinical significance of SF3B1 mutations in myelodysplastic syndromes and myelodysplastic/myeloproliferative neoplasms.
著者:: Malcovati, L, 等
出版事項: (2011)

MOLECULAR MAPPING OF UNCHARACTERISTICALLY SMALL 5Q DELETIONS IN 2 PATIENTS WITH THE 5Q- SYNDROME - DELINEATION OF THE CRITICAL REGION ON 5Q AND IDENTIFICATION OF A 5Q- BREAKPOINT
著者:: Boultwood, J, 等
出版事項: (1993)

Molecular mapping of uncharacteristically small 5q deletions in two patients with the 5q- syndrome: delineation of the critical region on 5q and identification of a 5q- breakpoint.
著者:: Boultwood, J, 等
出版事項: (1994)

Hematological features of patients with myelodysplastic syndromes associated with a chromosome 5q deletion.
著者:: Lewis, S, 等
出版事項: (1995)

Haploinsufficiency of ribosomal proteins and p53 activation in anemia: Diamond-Blackfan anemia and the 5q- syndrome.
著者:: Boultwood, J, 等
出版事項: (2012)

The 5q-syndrome.
著者:: Boultwood, J, 等
出版事項: (1994)

5q- syndrome.
著者:: Boultwood, J, 等
出版事項: (2012)

Induction of p53 and up-regulation of the p53 pathway in the human 5q- syndrome.
著者:: Pellagatti, A, 等
出版事項: (2010)